KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Cash from Operations: 2009-2024

Historic Cash from Operations for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Dec 2024 value amounting to $4.4 billion.

  • Regeneron Pharmaceuticals' Cash from Operations rose 25.36% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 billion, marking a year-over-year increase of 19.39%. This contributed to the annual value of $4.4 billion for FY2024, which is 3.78% down from last year.
  • According to the latest figures from FY2024, Regeneron Pharmaceuticals' Cash from Operations is $4.4 billion, which was down 3.78% from $4.6 billion recorded in FY2023.
  • In the past 5 years, Regeneron Pharmaceuticals' Cash from Operations registered a high of $7.1 billion during FY2021, and its lowest value of $2.6 billion during FY2020.
  • For the 3-year period, Regeneron Pharmaceuticals' Cash from Operations averaged around $4.7 billion, with its median value being $4.6 billion (2023).
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Cash from Operations spiked by 170.47% in 2021 and then declined by 29.18% in 2022.
  • Yearly analysis of 5 years shows Regeneron Pharmaceuticals' Cash from Operations stood at $2.6 billion in 2020, then spiked by 170.47% to $7.1 billion in 2021, then fell by 29.18% to $5.0 billion in 2022, then dropped by 8.39% to $4.6 billion in 2023, then dropped by 3.78% to $4.4 billion in 2024.